𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Plasma measurement of 7-dehydrocholesterol to detect carriers of Smith–Lemli–Opitz syndrome

✍ Scribed by Małgorzata J. M. Nowaczyk


Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
31 KB
Volume
20
Category
Article
ISSN
0197-3851

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Fetal Smith-Lemli-Opitz syndrome can be
✍ G. S. Tint; Dianne Abuelo; Marianne Till; M. P. Cordier; Ashok K. Batta; Sarah S 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 226 KB 👁 1 views

The Smith-Lemli-Opitz syndrome, characterized by limb, face and organ abnormalities, and mental retardation, is caused by an inherited block in the step of cholesterol biosynthesis in which the 7 double bond of 7-dehydrocholesterol is reduced. It is diagnosed by the presence of markedly elevated lev

Screening for abnormal cholesterol biosy
✍ Honda, Akira; Batta, Ashok K.; Salen, Gerald; Tint, G. Stephen; Chen, Thomas S.; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 2 views

The Smith-Lemli-Opitz syndrome (SLOS) is a common condition caused by deficiency of 7-dehydrocholesterol ⌬ 7 -reductase. The syndrome can usually be diagnosed by demonstrating markedly increased plasma concentrations of the cholesterol precursor, 7-dehydrocholesterol. We describe a simple and rapid

Fetal demise with Smith–Lemli–Opitz synd
✍ L. M. Linck; S. J. Hayflick; D. S. Lin; K. P. Battaile; S. Ginat; T. Burlingame; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB 👁 2 views

Smith±Lemli±Opitz syndrome (SLOS), an autosomal recessive condition with multiple malformations, mental retardation, and growth failure, results from markedly reduced activity of the ®nal enzyme in the cholesterol biosynthetic pathway, 7-dehydrocholesterol D 7 -reductase (DHCR7). We diagnosed SLOS i